FindMyRecallSubscribe
Class I: serious health riskTerminated

B. Braun Medical Cefepime for Injection and Dextrose Injection Recall

Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System,…

B. Braun Medical Inc · Irvine, CA

Risk level
Class I
Reported by FDA
Feb 12, 2014
Recall ID
D-1054-2014
Check your lot numberHow we source this data

Summary

B. Braun Medical recalled Cefepime for Injection and Dextrose Injection starting Oct 15, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-1054-2014 on Feb 12, 2014. Reason: Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.

Product description

Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, For IV Use Only, Single Dose, Sterile/Non pyrogenic, Rx Only, B Braun Medical Inc., NDC 0264-3193-11

Lot numbers, UPCs & expiration codes

Lot H3A744, Exp 01/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1054-2014
Classification
Class I
Status
Terminated
Recall initiated
Oct 15, 2013
FDA report date
Feb 12, 2014
Quantity
18,936 Containers
Recall type
Voluntary: Firm initiated
Recalling firm
B. Braun Medical Inc

Original FDA data

Every field from FDA enforcement report D-1054-2014, exactly as published.

Show all FDA fields
City
Irvine
State
CA
Status
Terminated
Country
United States
Event ID
66497
Address
2525 McGaw Ave
Code information
Lot H3A744, Exp 01/15
Postal code
92614-5841
Report date
Feb 12, 2014
Product type
Drugs
Recall number
D-1054-2014
Classification
Class I
Recalling firm
B. Braun Medical Inc
Product quantity
18,936 Containers
Termination date
Dec 4, 2014
Reason for recall
Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, For IV Use Only, Single Dose, Sterile/Non pyrogenic, Rx Only, B Braun Medical Inc., NDC 0264-3193-11
Distribution pattern
Nationwide
Recall initiation date
Oct 15, 2013
Initial firm notification
Press Release
Center classification date
Jan 31, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1054-2014, published Feb 12, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls